EssilorLuxottica Operating Income 2011-2023 | ESLOY
EssilorLuxottica annual/quarterly operating income history and growth rate from 2011 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- EssilorLuxottica operating income for the quarter ending December 31, 2023 was $M, a NAN% increase year-over-year.
- EssilorLuxottica operating income for the twelve months ending December 31, 2023 was $0M, a NAN% increase year-over-year.
- EssilorLuxottica annual operating income for 2023 was $3.438B, a 3.34% increase from 2022.
- EssilorLuxottica annual operating income for 2022 was $3.327B, a 20.91% increase from 2021.
- EssilorLuxottica annual operating income for 2021 was $2.752B, a 432.98% increase from 2020.
| EssilorLuxottica Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $3,438 |
| 2022 | $3,327 |
| 2021 | $2,752 |
| 2020 | $516 |
| 2019 | $1,879 |
| 2018 | $1,604 |
| 2017 | $1,214 |
| 2016 | $1,361 |
| 2015 | $1,314 |
| 2014 | $1,624 |
| 2013 | $1,218 |
| 2012 | $1,150 |
| 2011 | $1,042 |
| 2010 | $936 |
| EssilorLuxottica Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| 2015-12-31 | |
| 2015-06-30 | |
| 2014-12-31 | |
| 2014-06-30 | |
| 2013-12-31 | |
| 2013-06-30 | |
| 2012-12-31 | |
| 2012-06-30 | |
| 2011-12-31 | |
| 2011-06-30 | |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $111.024B | $27.483B |
| EssilorLuxottica Soci?t? is involved in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company's brand portfolio consists of Ray-Ban, Oakley, Varilux(R), Transitions(R), Sunglass Hut and LensCrafters. EssilorLuxottica Soci?t?, formerly known as Essilor International Soci?t? Anonyme, is based in Paris, France. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $199.931B | 25.50 |
| Stryker (SYK) | United States | $140.829B | 31.74 |
| Boston Scientific (BSX) | United States | $134.782B | 38.75 |
| Medtronic (MDT) | Ireland | $104.635B | 15.54 |
| Haleon (HLN) | United Kingdom | $44.090B | 28.65 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.326B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.417B | 18.89 |
| ResMed (RMD) | United States | $34.333B | 28.21 |
| Terumo (TRUMY) | Japan | $28.994B | 40.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.222B | 18.54 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.351B | 13.59 |
| Insulet (PODD) | United States | $18.636B | 74.21 |
| Baxter (BAX) | United States | $14.960B | 9.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.694B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.888B | 39.78 |
| Bio-Rad Laboratories (BIO) | United States | $9.278B | 31.53 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.483B | 15.06 |
| Haemonetics (HAE) | United States | $3.960B | 19.33 |
| Prestige Consumer Healthcare (PBH) | United States | $3.914B | 19.47 |
| ICU Medical (ICUI) | United States | $3.831B | 36.47 |
| Perrigo (PRGO) | Ireland | $3.548B | 10.45 |
| Envista Holdings (NVST) | United States | $3.328B | 24.80 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $3.000B | 19.31 |
| GN Store Nord (GNNDY) | Denmark | $2.779B | 17.82 |
| Neogen (NEOG) | United States | $2.694B | 31.08 |
| LeMaitre Vascular (LMAT) | United States | $2.114B | 51.39 |
| Green Thumb Industries (GTBIF) | United States | $1.638B | 28.67 |
| AtriCure (ATRC) | United States | $1.499B | 0.00 |
| InMode (INMD) | Israel | $1.453B | 8.74 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.417B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.317B | 9.41 |
| BioLife Solutions (BLFS) | United States | $1.254B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.014B | 0.00 |
| Owens & Minor (OMI) | United States | $1.000B | 7.81 |
| CeriBell (CBLL) | United States | $0.949B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.878B | 15.49 |
| Evolus (EOLS) | United States | $0.719B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.640B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.621B | 27.40 |
| Omeros (OMER) | United States | $0.606B | 0.00 |
| Surmodics (SRDX) | United States | $0.567B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.438B | 0.00 |
| Quanterix (QTRX) | United States | $0.425B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.414B | 0.00 |
| ZimVie (ZIMV) | United States | $0.389B | 32.81 |
| Valneva SE (VALN) | France | $0.341B | 0.00 |
| Biote (BTMD) | United States | $0.335B | 7.35 |
| Viemed Healthcare (VMD) | United States | $0.318B | 30.26 |
| Canopy Growth (CGC) | Canada | $0.309B | 0.00 |
| Cerus (CERS) | United States | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.299B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.272B | 18.20 |
| Zynex (ZYXI) | United States | $0.265B | 55.47 |
| High Tide (HITI) | Canada | $0.259B | 107.33 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.209B | 14.42 |
| MacroGenics (MGNX) | United States | $0.205B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.201B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.194B | 2.73 |
| Jin Medical (ZJYL) | China | $0.186B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.184B | 0.00 |
| Brainsway (BWAY) | Israel | $0.176B | 93.70 |
| TriSalus Life Sciences (TLSI) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.58 |
| Quipt Home Medical (QIPT) | United States | $0.108B | 0.00 |
| Veru (VERU) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 10.93 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Exagen (XGN) | United States | $0.089B | 0.00 |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.070B | 36.00 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Safety Shot (SHOT) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.042B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.81 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |